AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Guideline | Open Access

Chinese clinical practice guidelines for the prevention and treatment of radiation-induced rectal injury

Hui Zhang1Zhen Zhang1,2,3,4( )Shuanghu Yuan2,3,4,5 ( )
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
China Anti-Cancer Association Tumor Support Therapy Committee
China Anti-Cancer Association Tumor Radiation Protection Committee
Chinese Radiation Therapy Oncology Group
Department of Radiology, Shandong Cancer Hospital, Jinan, China
Show Author Information

Abstract

Although radiotherapy plays an important role in the treatment of cancer, it may have negative effects in some individuals. Rectal injury is a common adverse effect of abdominal and pelvic radiotherapy. This injury is caused by administering radiation to the abdomen. Appropriate treatment techniques can be determined if doctors have a better understanding of the incidence, risk factors, and clinical symptoms of radiation-induced rectal injuries. Studies on the underlying pathophysiology of radiation-induced rectal injury may aid in the development of effective treatment and prevention strategies. The implementation of efficient preventive measures can improve the quality of life of patients with cancer and make it easier for them to complete their treatment. Therefore, comprehensive and accurate assessments are crucial for developing holistic and individualized treatment plans for patients who have already developed symptoms, with early intervention being a priority.

References

1

Weiner JP, Wong AT, Schwartz D, et al. Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding. World J Gastroenterol. 2016;22(31):6972-6986.

2

Tagkalidis PP, Tjandra JJ. Chronic radiation proctitis. ANZ J Surg. 2001;71(4):230-237.

3

Dahiya DS, Kichioo A, Tuma F, et al. Radiation proctitis and management strategies. Clin Endosc. 2022;55(1):22-32.

4

Tohidinezhad F, Willems Y, Berbee M, et al. Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review. J Contemp Brachytherapy. 2022;14(4):411-422.

5

Wang CJ, Huang EY, Sun LM, et al. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2004;59(1):179-189.

6

Michalski JM, Yan Y, Watkins-Bruner D, et al. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013;87(5):932-938.

7

Ngan SY, Burmelster B, Fisher RJ, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol. 2012;30(31):3827-3833.

8

Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93(10):1215-1223.

9

Morris KA, Haboubi NY. Pelvic radiation therapy: between delight and disaster. World J Gastrointest Surg. 2015;7(11):279-288.

10

Haboubi NY, El-Zammer O, O’Dwyer ST, et al. Radiation bowel disease: pathogenesis and management. Colorectal Dis. 2000;2(6):322-329.

11

Williams JM, Duckworth CA, Burkitt MD, et al. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol. 2015;52(3):445-455.

12

Grodsky MB, Sidani SM. Radiation proctopathy. Clin Colon Rectal Surg. 2015;28(2):103-111.

13

Shadad AK, Sullivan FJ, Martin JD, et al. Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol. 2013;19(2):185-198.

14

Haboubi NY, Schofield PF, Rowland PL. The light and electron microscopic features of early and late phase radiation-induced proctitis. Am J Gastroenterol. 1988;83(10):1140-1144.

15

Hasleton PS, Carr N, Schofield PF. Vascular changes in radiation bowel disease. Histopathology. 1985;9(5):517-534.

16

Li Y, Ding Q, Gao J, et al. Novel mechanisms underlying inhibition of inflammation-induced angiogenesis by dexamethasone and gentamicin via PI3K/AKT/NF-κB/VEGF pathways in acute radiation proctitis. Sci Rep. 2022;12(1):14116.

17

Okunieff P, Cormelison T, Mester M, et al. Mechanism and modification of gastrointestinal soft tissue response to radiation: role of growth factors. Int J Radiat Oncol Biol Phys. 2005;62(1):273-278.

18

Zeng Q, Cheng J, Wu H, et al. The dynamic cellular and molecular features during the development of radiation proctitis revealed by transcriptomic profiling in mice. BMC Genomics. 2022;23(1):431.

19

Takeuchi H, Kimura T, Okamoto K, et al. A mechanism for abnormal angiogenesis in human radiation proctitis: analysis of expression profile for angiogenic factors. J Gastroenterol. 2012;47(1):56-64.

20

Huang S, Wang X, Sun Y, et al. TMT-labelled quantitative proteomic analysis to identify the proteins underlying radiation-induced colorectal fibrosis in rats. J Proteomics. 2020;223:103801.

21

Kosmacek EA, Oberley-Deegan RE. Adipocytes protect fibroblasts from radiation-induced damage by adiponectin secretion. Sci Rep. 2020;10(1):12616.

22

Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-1346.

23

Cao XP. Radiation intestinal injury in the era of precision radiotherapy. Zhonghua Wei Chang Wai Ke Za Zhi. 2020;23(8):734-736.

24

Ng SY, Colborn KL, Cambridge L, et al. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer. Radiother Oncol. 2016;121(2):252-257.

25

Zhou Y, Huang H, Wan T, et al. Chronic radiation-induced rectal injury after adjuvant radiotherapy for pelvic malignant tumors: report based on a phase 3 randomized clinical trial]. Zhonghua Wei Chang Wai Ke Za Zhi. 2021;24(11):962-968.

26

Spampinato S, Jensen NBK,Pötter R, et al.Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer:lessons learned from EMBRACE-I and implications for the future. Int J Radiat Oncol Biol Phys. 2022;112(3):681-693.

27

Cola LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys. 1995;31(5):1213-1236.

28

Michalski JM, Gay H, Jackson A, et al. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76:S123-129.

29

Kotabe K, Nakayama H, Takashi A, et al. Association between rectal bleeding and the absolute dose volume of the rectum following image-guided radiotherapy for patients with prostate cancer. Oncol Lett. 2018;16(2):2741-2749.

30

Kim TG, Park B, Song YG, et al. Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study. Radiat Oncol. 2022;17(1):30.

31

Yang TJ, Oh JH, Son CH, et al. Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer. Gastrointest Cancer Res: GCR. 2013;6:129-136.

32

Zhang H, Wang M, Shi T, et al. Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy. OncoTargets Ther. 2015;8:2291-2301.

33

Zhang H, Wang M, Shi T, et al. TNF rs1799964 as a predictive factor of acute toxicities in Chinese rectal cancer patients treated with chemoradiotherapy. Medicine. 2015;94(45):e1955.

34

Schirmer MA, Mergler CP, Rave-Fränk M, et al. Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant. Int J Radiat Oncol Biol Phys. 2012;83(1):149-157.

35

Zhu J, Liu A, Sun X, et al.Multicenter, randomized, phase Ⅲ trial of neoadjuvant chemoradiation with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer. J Clin Oncol. 2020;38(36):4231-4239.

36

O’reilly M, Mellotte G, Ryan B, et al. Gastrointestinal side effects of cancer treatments. Ther Adv Chronic Dis. 2020;11:2040622320970354.

37
LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 1995;31(5):1049-1091.
38

Freites-Martinez A, Santana N, Arias-Santiago S, et al. Using the common terminology criteria for adverse events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr (Engl Ed). 2021;112(1):90-92.

39

Hille A, Schmidt-Giese E, Hermann RM, et al. A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment. Scand J Gastroenterol. 2008;43(1):52-58.

40

Hille A, Rave-Fränk M, Christiansen H, et al. Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study. Scand J Gastroenterol. 2009;44(8):939-946.

41

Ferini G, Pergolizzi S. A ten-year-long update on radiation proctitis among prostate cancer patients treated with curative external beam radiotherapy. In Vivo. 2021;35(3):1379-1391.

42

Wortel RC, Incrocci L, Pos FJ, et al. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2015;91(4):737-744.

43

Wortel RC, Incrocci L, Pos FJ, et al. Late side effects after image guided intensity modulated radiation therapy compared to 3D-conformal radiation therapy for prostate cancer: results from 2 prospective cohorts. Int J Radiat Oncol Biol Phys. 2016;95(2):680-689.

44

Yu K, Zhou L. Intensity-modulated radiotherapy and three-dimensional conformal radiotherapy combined with intracavitary posterior radiotherapy for the treatment of medium-term and advanced cervical cancer: efficacy, safety and prognostic factors. Front Surg. 2022;9:906117.

45

Podder TK, Fredman ET, Ellis RJ. Advances in radiotherapy for prostate cancer treatment. Adv Exp Med Biol. 2018;1096:31-47.

46

Beltran C, Schultz HL, Anand A, et al. Radiation biology considerations of proton therapy for gastrointestinal cancers. J Gastrointest Oncol. 2020;11(1):225-230.

47

Wu Y, Liu C, Wang W, et al. Study on appropriate rectal volume for external irradiation in patients with cervical cancer. Front Oncol. 2022;12:814414.

48

Ben-Josef E, Han S, Tobi M, et al. Intrarectal application of amifostine for the prevention of radiation-induced rectal injury. Semin Radiat Oncol. 2002;12:81-85.

49

Athanassiou H, Antonadou D, Coliarakis N, et al. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys. 2003;56(4):1154-1160.

50

Khan AM, Birk JW, Anderson JC, et al. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients. The Am J Gastroenterol. 2000;95(8):1961-1966.

51

Jahraus CD, Bettenhausen D, Malik U, et al. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2005;63(5):1483-1487.

52

Saei S, Sahebnasagh A, Ghasemi A, et al. Efficacy of sucralfate ointment in the prevention of acute proctitis in cancer patients: A randomized controlled clinical trial. Caspian J Intern Med. 2020;11(4):410-418.

53

Hovdenak N, Sørbye H, Dahl O. Sucralfate does not ameliorate acute radiation proctitis: randomised study and meta-analysis. Clin Oncol (R Coll Radiol). 2005;17(6):485-491.

54

O’brien PC, Franklin CI, Poulsen MG, et al. Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase Ⅲ trial–Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2002;54(2):442-449.

55

O’brien PC, Franklin CI, Dear KB, et al. A phase Ⅲ double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis. Radiother Oncol. 1997;45(2):117-123.

56

Sahebnasagh A, Saghafi F, Ghasemi A, et al. Aloe vera for prevention of acute radiation proctitis in colorectal cancer a preliminary randomized, placebo-controlled clinical trial. J Gastrointest Cancer. 2022;53(2):318-325.

57

Nascimento M, Aguilar-Nascimento JE, Caporossi C, et al. Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial. Int J Radiat Oncol Biol Phys. 2014;90(2):289-295.

58

Cosentino D, Piro F. Hyaluronic acid for treatment of the radiation therapy side effects: a systematic review. Eur Rev Med Pharmacol Sci. 2018;22(21):7562-7572.

59

Araujo IK, Muñoz-Guglielmetti D, Mollà M. Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options. Best Pract Res Clin Gastroenterol. 2020;48–49:101707.

60

Ali F, Hu KY. Evaluation and management of chronic radiation proctitis. Dis Colon Rectum. 2020;63(3):285-287.

61

Porouhan P, Farshchian N, Dayani M. Management of radiation-induced proctitis. J Family Med Prim Care. 2019;8(7):2173-2178.

62

Tabaja L, Sidani SM. Management of radiation proctitis. Dig Dis Sci. 2018;63(9):2180-2188.

63

Bansal N, Soni A, Kaur P, et al. Exploring the management of radiation proctitis in current clinical practice. J Clin Diagn Res: JCDR. 2016;10(6):XE01-XE06.

64

Leiper K, Morris AI. Treatment of radiation proctitis. Clin Oncol (R Coll Radiol). 2007;19(9):724-729.

65

Paquette IM, Vogel JD, Abbas MA, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Chronic Radiation Proctitis. Dis Colon Rectum. 2018;61(10):1135-1140.

66

Wang L, Wang J. Chinese consensus on diagnosis and treatment of radiation proctitis (2018). Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(12):1321-1336.

67

Colorectal Surgery Group, Branch of Surgery, Chinese Medical Association; Colorectal Surgeon Committee, Surgeon Branch, Chinese Medical Doctor Association; Colorectal Cancer Professional Committee, Anti-Cancer Association of China. Chinese expert consensus on multidisciplinary diagnosis and treatment of radiation rectal injury (2021 edition). Zhonghua Wei Chang Wai Ke Za Zhi. 2021;24(11):937-949.

68

Webb GJ, Brooke R, De Silva AN. Chronic radiation enteritis and malnutrition. J Dig Dis. 2013;14(7):350-357.

69

Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5):2898-2913.

70

Kim MJ, Shin R, Oh HK, et al. The impact of heavy smoking on anastomotic leakage and stricture after low anterior resection in rectal cancer patients. World J Surg. 2011;35(12):2806-2810.

71

Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psy. 2020;25(7):1487-1499.

72

Gillespie C, Goode C, hackett C, et al. The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2007;26(4):555-563.

73

Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study.primary care evaluation of mental disorders.patient health questionnaire. JAMA. 1999;282(18):1737-1744.

74

Moriana JA, Jurado-GonzÁlez FJ, GarcÍa-Torres F, et al. Exploring the structure of the GAD-7 scale in primary care patients with emotional disorders: a network analysis approach. J Clin Psychol. 2022;78(2):283-297.

75

Huh JW, Tanksley J, Chino J, et al. Long-term consequences of pelvic irradiation: toxicities, challenges, and therapeutic opportunities with pharmacologic mitigators. Clin Cancer Res. 2020;26(13):3079-3090.

76

Hongyu Li, Xiangbo Xu, Xingshun Qi, et al. Current status of probiotics in the treatment of radiation-induced enteritis. Modern Digestion and Interventional Diagnostics and Therapeutics. 2021;26(4):514-516.

77

Nascimento M, Caporossi C, Eduardo Aguilar-Nascimento J, et al. Efficacy of synbiotics to reduce symptoms and rectal inflammatory response in acute radiation proctitis: a randomized, double-blind, placebo-controlled pilot trial. Nutr Cancer. 2020;72(4):602-609.

78

Cavcić J, Turcić J, Martinac P, et al. Metronidazole in the treatment of chronic radiation proctitis: clinical trial. Croat Med J. 2000;41(3):314-318.

79

Sahakitrungruang C, Patiwongpaisarn A, Kanjanasilp P, et al. A randomized controlled trial comparing colonic irrigation and oral antibiotics administration versus 4% formalin application for treatment of hemorrhagic radiation proctitis. Dis Colon Rectum. 2012;55(10):1053-1058.

80

Seo EH, Kim TO, Kim TG, et al. The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis. Dig Dis Sci. 2011;56(9):2672-2677.

81

Kilic D, Ozenirler S, Egehan I, et al. Sulfasalazine decreases acute gastrointestinal complications due to pelvic radiotherapy. Ann Pharmacother. 2001;35(7/8):806-810.

82

Li H, Bai C, Qi X, et al. Progress in the application of glucocorticoids in radiation-induced enteritis. Chin J Dig. 2021;41(1):68-70.

83

Kochhar R, Sharma SC, Gupta BB, et al. Rectal sucralfate in radiation proctitis. Lancet. 1988;2(8607):400.

84

Kochhar R, Patel F, Dhar A, et al. Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci. 1991;36(1):103-107.

85

Kochhar R, Sriram PV, Sharma SC, et al. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension. Dig Dis Sci. 1999;44(5):973-978.

86

Chruscielewska-Kiliszek MR, Regula J, Polkowski M, et al. Sucralfate or placebo following argon plasma coagulation for chronic radiation proctitis: a randomized double blind trial. Colorectal Dis. 2013;15(1):e48-e55.

87

Mcelvanna K, Wilson A, Irwin T. Sucralfate paste enema: a new method of topical treatment for haemorrhagic radiation proctitis. Colorectal Dis. 2014;16(4):281-284.

88

Ehrenpreis ED, Jani A, Levitsky J, et al. A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy. Dis Colon Rectum. 2005;48(1):1-8.

89

Kennedy M, Bruninga K, Mutlu EA, et al. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol. 2001;96(4):1080-1084.

90

Vernia P, Fracasso PL, Casale V, et al. Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet. 2000;356(9237):1232-1235.

91

Hille A, Herrmann MK, Kertesz T, et al. Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation. Strahlenther Onkol. 2008;184(12):686-692.

92

Maggio A, Magli A, Rancati T, et al. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study. Int J Radiat Oncol Biol Phys. 2014;89(3):518-524.

93

Pinto A, Fidalgo P, Cravo M, et al. Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum. 1999;42(6):788-795.

94

Talley NA, Chen F, King D, et al. Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trial. Dis Colon Rectum. 1997;40(9):1046-1050.

95

The Chinese Radiation Therapy Oncology Group. Guidelines for the prevention and treatment of acute mucositis associated with radiation therapy for head and neck tumors. Chin J Cancer Prev Treat. 2022;29(2):79-91.

96

Liu Y, Fang S, Li Q. Efficacy observation of recombinant human granulocyte-macrophage colony stimulating factor combined with traditional medicine retention enema for treatment of chronic radiation proctitis in patients with cervical cancer and endometrial cancer. Cancer Res Clin. 2021;33(5):349-352.

97

Zhang J, Gong C, Qin K, et al. Effect of Kangfuxin Fluid Combined with Compound Berberine Retention Enema in the Treatment of 25 Cases of Patients with Radiotherapy-induced Acute Proctitis. Herald Med. 2019;38(8):1030-1032.

98

Han J, Gong C, Peng P, et al. Application of Bifidobacterium Triple Viable Powder and Compound Berberine Retention Enema in Preventing Acute Radiation Proctitis. Anti-Tumor Pharm. 2020;10(1):103-106.

99

Dalsania RM, Shah KP, Stotsky-Himelfarb E, et al. Management of long-term toxicity from pelvic radiation therapy. Am Soc Clin Oncol Educ Book. 2021;41:1-11.

100

Luna-Pérez P, RodrÍguez-ramÍrez SE. Formalin instillation for refractory radiation-induced hemorrhagic proctitis. J Surg Oncol. 2002;80(1):41-44.

101

De Parades V, Etienney I, Bauer P, et al. Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis–an effective but not risk-free procedure:a prospective study of 33 patients. Dis Colon Rectum. 2005;48(8):1535-1541.

102

Lian Y, Wu M, Zhao D, et al. Systematic Evaluation of Chinese Medicine Enema in the Treatment of Radiation Enteritis. World Chin Med. 2021;16(16):2435-2444.

103

Zhang Z, Ma L, Zhao C, et al. Research progress of TCM in treating radiation enteritis based on intestinal microecology. Int J Tradit Chin Med. 2022;44(8):959-961.

104

Lu W, Gao L, Li G, et al. Preventive and Therapeutic Effect of Chinese Medicine Patent Preparation on Radiation Enteritis. J Oncol Chin Med. 2020;2(2):94-97.

105

Sato Y, Takayama T, Sagawa T, et al. Argon plasma coagulation treatment of hemorrhagic radiation proctopathy: the optimal settings for application and long-term outcome. Gastrointest Endosc. 2011;73(3):543-549.

106

Weiner J, Schwartz D, Martinez M, et al. Long-term results on the efficacy of argon plasma coagulation for patients with chronic radiation proctitis after conventionally fractionated, dose-escalated radiation therapy for prostate cancer. Pract Radiat Oncol. 2017;7(1):e35-e42.

107

Furtado FS, Furtado GB, Oliveira AT, et al. Endorectal formalin instillation or argon plasma coagulation for hemorrhagic radiation proctopathy therapy: a prospective and randomized clinical trial. Gastrointest Endosc. 2021;93(6):1393-1400.

108

Yeoh E, Tam W, Schoeman M, et al. Argon plasma coagulation therapy versus topical formalin for intractable rectal bleeding and anorectal dysfunction after radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 2013;87(5):954-959.

109

Jensen DM, Machicado GA, Cheng S, et al. A randomized prospective study of endoscopic bipolar electrocoagulation and heater probe treatment of chronic rectal bleeding from radiation telangiectasia. Gastrointest Endosc. 1997;45(1):20-25.

110

Lenz L, Tafarel J, Correia L, et al. Comparative study of bipolar eletrocoagulation versus argon plasma coagulation for rectal bleeding due to chronic radiation coloproctopathy. Endoscopy. 2011;43(8):697-701.

111

Barbatzas C, spencer GM, Thorpe SM, et al. Nd: YAG laser treatment for bleeding from radiation proctitis. Endoscopy. 1996;28(6):497-500.

112

Taylor JG, Disario JA, Bjorkman DJ. KTP laser therapy for bleeding from chronic radiation proctopathy. G astrointest Endosc. 2000;52(3):353-357.

113

Rustagi T, Corbett FS, Mashimo H.Treatment of chronic radiation proctopathy with radiofrequency ablation (with video). Gastrointest Endosc. 2015;81(2):428-436.

114

Lamonaca L, Auriemma F, Paduano D, et al. Rectal band ligation as a treatment for chronic radiation proctitis: a feasibility study. Endosc Int Open. 2022;10(6):E787-E790.

115

Triadafilopoulos G, Sarkisian M. Dilatation of radiation-induced sigmoid stricture using sequential Savary-Guilliard dilators. A combined radiologic-endoscopic approach. Dis Colon Rectum. 1990;33(12):1065-1067.

116

Clarke RE, Tenorio LM, Hussey JR, et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;72(1):134-143.

117

Glover M, Smerdon GR, Andreyev HJ, et al. Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial. Lancet Oncol. 2016;17(2):224-233.

118

Geldof NI, Van Hulst RA, Ridderikhof ML, et al. Hyperbaric oxygen treatment for late radiation-induced tissue toxicity in treated gynaecological cancer patients: a systematic review. Radiat Oncol. 2022;17(1):164.

119

Wang Z, Wang Q, Wang X, et al. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy. J Cell Mol Med. 2019;23(5):3747-3756.

120

Manichanh C, Varela E, Martinez C, et al. The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol. 2008;103(7):1754-1761.

121

Reis Ferreira M, Andreyev HJN, Mohammed K, et al. Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: A large pilot study of the microbiome in acute and late-radiation enteropathy. Clin Cancer Res. 2019;25(21):6487-6500.

122

Ding X, Li Q, Li P, et al. Fecal microbiota transplantation: a promising treatment for radiation enteritis? Radiother Oncol. 2020;143:12-18.

123

Ning Li, Tian H, Chen Q, et al. Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders. Chin J Gastrointest Surg. 2019;22(9):861-868.

124

Pricolo VE, Shellito PC. Surgery for radiation injury to the large intestine. Variables influencing outcome. Dis Colon Rectum. 1994;37(7):675-684.

125

Mccrone LF, Neary PM, Larkin J, et al. The surgical management of radiation proctopathy. Int J Colorectal Dis. 2017;32(8):1099-1108.

126

Ayerdi J, Moinuddeen K, Loving A, et al. Diverting loop colostomy for the treatment of refractory gastrointestinal bleeding secondary to radiation proctitis. Mil Med. 2001;166(12):1091-1093.

127

Goldberg M, Aukett LK, Carmel J, et al. Management of the patient with a fecal ostomy: best practice guideline for clinicians. J Wound Ostomy Cont. 2010;37(6):596-598.

128

Marks G, Mohiudden M. The surgical management of the radiation-injured intestine. Surg Clin North Am. 1983;63(1):81-96.

Precision Radiation Oncology
Pages 237-255
Cite this article:
Zhang H, Zhang Z, Yuan S. Chinese clinical practice guidelines for the prevention and treatment of radiation-induced rectal injury. Precision Radiation Oncology, 2023, 7(4): 237-255. https://doi.org/10.1002/pro6.1217

166

Views

0

Crossref

0

Scopus

Altmetrics

Received: 17 August 2023
Revised: 19 November 2023
Accepted: 20 November 2023
Published: 25 December 2023
© 2023 The Authors.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Return